Items Tagged ‘John Cheville’
July 1, 2014
By AJ Montpetit 
George Vasmatzis, Ph.D., and John Cheville, M.D., co-directors of the Biomarker Program at the Center for Individualized Medicine at Mayo Clinic, introduce us to the world and work of Biomarkers. The Biomarker Discovery Program is a multidisciplinary team that includes oncologists, surgeons, pathologists, molecular biologists, bioengineers, bioinformaticians and others. By combining expertise, the program takes a clinical […]
Tags: biomarker, Biomarker Discovery Program, biomarkers, Bladder Cancer, breast cancer, center for individualized medicine, dna test, DNA Testing, gene sequencing, genome science, genomic medicine, genomics
June 17, 2014
By AJ Montpetit
George Vasmatzis, Ph.D., and John Cheville, M.D., co-directors of the Biomarker Program at the Center for Individualized Medicine at Mayo Clinic, introduce us to the world and work of Biomarkers. Biomarkers are molecular substances in the body that can be used to indicate health or disease. These biomarkers can be found in tissue, blood, urine […]
Tags: biomarker, biomarkers, cancer, center for individualized medicine, DNA, dna test, DNA Testing, gene sequencing, Genetics, genome, genome science, Genome Sequencing
January 21, 2014
Genomics Opens Door for New Application of Breast Cancer Drug for Bladder Cancer Patients
Researchers at Mayo Clinic have found amplification of the gene HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that it’s presence is associated with particularly aggressive tumors. These findings suggest that administering trastuzumab to MPUC patients with HER2 amplification could improve outcomes, […]
Tags: biomarker, Biomarker Discovery Program, biomarkers, Bladder Cancer, breast cancer, center for individualized medicine, dna test, DNA Testing, gene sequencing, genome science, genomic medicine, genomics